Biotricity Inc. (BTCY) financial statements (2021 and earlier)

Company profile

Business Address 275 SHORELINE DRIVE
REDWOOD CITY, CA 94065
State of Incorp. NV
Fiscal Year End March 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q3
9/30/2020
Q2
6/30/2020
Q1
3/31/2020
Q4
12/31/2019
Q3
9/30/2019
Q2
6/30/2019
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3001400
Cash and cash equivalents3001400
Receivables1110100
Inventory, net of allowances, customer advances and progress billings0000000
Inventory0000000
Deposits current assets0000000
Other undisclosed current assets (0)  000
Total current assets:5212511
Noncurrent Assets
Operating lease, right-of-use asset0000000
Deposits noncurrent assets   0000
Other undisclosed noncurrent assets0000   
Total noncurrent assets:0000000
TOTAL ASSETS:5212611
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3222222
Accounts payable1111111
Accrued liabilities1110111
Other undisclosed accounts payable and accrued liabilities  (0)    
Debt6222400
Derivative instruments and hedges, liabilities 3     
Other undisclosed current liabilities0000 42
Total current liabilities:8744764
Noncurrent Liabilities
Long-term debt and lease obligation   0000
Operating lease, liability   0000
Liabilities, other than long-term debt61111  
Derivative instruments and hedges, liabilities61111  
Other undisclosed noncurrent liabilities222    
Total noncurrent liabilities:7231100
Total liabilities:16965764
Stockholders' equity
Stockholders' equity attributable to parent, including:(11)(7)(5)(3)(2)(5)(3)
Preferred stock0000000
Common stock0000000
Additional paid in capital47464644413534
Accumulated other comprehensive loss(1)(1)(1)(1)(1)(1)(1)
Accumulated deficit(57)(53)(50)(46)(42)(39)(37)
Other undisclosed stockholders' equity attributable to parent0000000
Other undisclosed stockholders' equity  0 0  
Total stockholders' equity:(11)(7)(5)(3)(2)(5)(3)
TOTAL LIABILITIES AND EQUITY:5212611

Income statement (P&L) ($ in millions)

12/31/2020
Q3
9/30/2020
Q2
6/30/2020
Q1
3/31/2020
Q4
12/31/2019
Q3
9/30/2019
Q2
6/30/2019
Q1
Revenues1101000
Cost of revenue(1)(0)(0)(1)(0)(0)(0)
Gross profit:0001000
Operating expenses(4)(3)(4)(5)(3)(2)(2)
Operating loss:(4)(3)(3)(4)(2)(2)(2)
Nonoperating income
(Other Nonoperating income)
0      
Loss from continuing operations before equity method investments, income taxes:(4)(3)(3)(4)(2)(2)(2)
Other undisclosed income (loss) from continuing operations before income taxes(0)(0)0(0)(0)  
Net loss:(4)(3)(3)(4)(2)(2)(2)
Other undisclosed net loss attributable to parent(0)      
Net loss attributable to parent:(4)(3)(3)(4)(2)(2)(2)
Preferred stock dividends and other adjustments(0)(0)(0) (0)  
Other undisclosed net income (loss) available to common stockholders, basic0  (0)   
Net loss available to common stockholders, diluted:(4)(3)(3)(5)(2)(2)(2)

Comprehensive Income ($ in millions)

12/31/2020
Q3
9/30/2020
Q2
6/30/2020
Q1
3/31/2020
Q4
12/31/2019
Q3
9/30/2019
Q2
6/30/2019
Q1
Net loss:(4)(3)(3)(4)(2)(2)(2)
Comprehensive loss:(4)(3)(3)(4)(2)(2)(2)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)(0)(1)(0)(0)(0)
Comprehensive loss, net of tax, attributable to parent:(4)(3)(3)(5)(3)(2)(2)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: